| Financial Year |
March 31 2022 |
| Monetary Funds |
287,840,046.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,395,419.48 |
| Accounts Receivable |
5,552,348.34 |
| Advances to Suppliers |
23,734,488.66 |
| Other Receivables |
23,685,490.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
47,539,655.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,652,015.98 |
| Total Current Assets |
393,399,464.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
80,189,961.62 |
| Under-construction Projects |
4,633,779.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,944,440.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,414,401.78 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
111,307,473.39 |
| Total Assets |
504,706,938.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
206,807,719.64 |
| Accounts Payable |
81,858,377.09 |
| Accounts Received In Advance |
22,302,720.00 |
| Employee Compensation Payable |
2,474,177.68 |
| Taxes Payable |
1,604,275.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
130,508,941.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,228,412.39 |
| Other Current Liabilities |
1,277,980.43 |
| Sub-Total of Current Liabilities |
457,893,222.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,410,808.42 |
| Total Liabilities |
462,304,031.07 |
| Paid-In Capital(Or Share Stock) |
432,475,779.00 |
| Capital Surplus |
1,027,351,290.22 |
| Surplus Reserve |
28,894,524.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,446,318,686.30 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
42,402,906.95 |
| Owner's Equity（Stockholder's Equity） |
42,402,906.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
504,706,938.02 |
